Abstract
Efficacy of infliximab in neuro-Behçet’s disease presenting with isolated longitudinally extensive transverse myelitis
Highlights
Behcet’s disease (BD) is a relapsing systemic inflammatory disorder of unknown etiology, showing common characteristics of oral and genital ulcers and uveitis
Use of tumor necrosis factor (TNF)-alpha antagonist therapy has been described for neuro-Behcet’s disease (NBD) [6,7,8]
Reports of NBD with spinal cord involvement describing the efficacy of anti-TNF-alpha therapy are scarce [9]
Summary
Behcet’s disease (BD) is a relapsing systemic inflammatory disorder of unknown etiology, showing common characteristics of oral and genital ulcers and uveitis. In NBD, the frequency of spinal cord involvement is 8–14 % [4, 5]. Use of tumor necrosis factor (TNF)-alpha antagonist therapy has been described for NBD [6,7,8]. Reports of NBD with spinal cord involvement describing the efficacy of anti-TNF-alpha therapy are scarce [9].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have